Braingaze
Next-generation eye tracking software that identifies and predicts personal behaviour, with both clinical and commercial applications.
- B2B
- saas
- subscription
- health
- enterprise software
- medical devices
- biotechnology
- artificial intelligence
- hardware
- big data
- deep tech
- biotechnology
- horizon europe
- dt and ls
- spinout
- core ai
- analytics
- ai applications
- testing
- eit ecosystem
- predictive analytics
- packaging and containers
- neurology
- medical testing
- user behavior
- mental health
- eit health
- commerce
- non-invasive medical devices and treatments
- tracking
- health it
- physician support tools
- health diagnostics
- clinical decision support
- headstart (eit health)
- digital therapeutics
- eic
- behavior analytics
- packaging
- european health catapult (eit health)
- investor network (eit health)
- headstart 2018 (eit health)
- pediatrics
- investor network 2018 (eit health)
- eye tracking
- european health catapult 2019 (eit health)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
* | €1.5m | Seed | |
| Total Funding | 000k | ||
| EUR | 2015 | 2018 | 2019 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | 46 % | - | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 79 % | 22 % | - | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 65 % | (7 %) | (19 %) | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
Braingaze is a pioneering startup in the mental health diagnostics and therapy sector, leveraging advanced technology to streamline and enhance the diagnosis and treatment of mental health disorders, particularly ADHD (Attention Deficit Hyperactivity Disorder). The company operates in the healthcare market, specifically focusing on mental health clinics and professionals who diagnose and treat cognitive disorders.
Braingaze offers two primary products: BGaze Clinic and BGaze Therapy. BGaze Clinic is an AI-powered diagnostic software that uses advanced eye-tracking hardware to capture involuntary eye movements, which serve as biomarkers (biological indicators) for diagnosing mental health conditions. This system provides clinics with highly accurate, objective diagnostic results, saving time and improving patient interactions.
BGaze Therapy, on the other hand, is a child-friendly game designed to improve attention skills. It is particularly beneficial for children with cognitive profiles such as ADHD, Autism Spectrum Disorder (ASD), and Dyslexia. The therapy involves games controlled by eye movements, where players earn points by focusing, following, or avoiding objects on the screen. This method trains the brain's attention network and helps control impulsivity. Scientific studies have validated BGaze Therapy, showing significant improvements in patients' attentional capabilities and impulse control.
Braingaze's business model revolves around selling its diagnostic and therapeutic software to mental health clinics and professionals. The company generates revenue through the sale of its software and hardware packages, as well as through ongoing service and support subscriptions.
In summary, Braingaze is revolutionizing mental healthcare by integrating AI and advanced eye-tracking technology into diagnostic and therapeutic processes. This approach not only enhances diagnostic accuracy and objectivity but also provides engaging and effective therapeutic solutions for children with cognitive disorders.
Keywords: AI, ADHD, mental health, diagnostics, therapy, eye-tracking, children, cognitive disorders, healthcare, technology.